Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic.
Lee VH, Adham M, Ben Kridis W, Bossi P, Chen MY, Chitapanarux I, Gregoire V, Hao SP, Ho C, Ho GF, Kannarunimit D, Kwong DL, Lam KO, Lam WKJ, Le QT, Lee AW, Lee NY, Leung TW, Licitra L, Lim DW, Lin JC, Loh KS, Lou PJ, Machiels JP, Mai HQ, Mesía R, Ng WT, Ngan RK, Tay JK, Tsang RK, Tong CC, Wang HM, Wee JT. Lee VH, et al. Among authors: tong cc. Lancet Oncol. 2022 Dec;23(12):e544-e551. doi: 10.1016/S1470-2045(22)00505-8. Lancet Oncol. 2022. PMID: 36455583 Free PMC article. Review.
The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.
Lee VH, Kwong DL, Leung TW, Choi CW, O'Sullivan B, Lam KO, Lai V, Khong PL, Chan SK, Ng CY, Tong CC, Ho PP, Chan WL, Wong LS, Leung DK, Chan SY, So TH, Luk MY, Lee AW. Lee VH, et al. Among authors: tong cc. Int J Cancer. 2019 Apr 1;144(7):1713-1722. doi: 10.1002/ijc.31856. Epub 2018 Dec 24. Int J Cancer. 2019. PMID: 30192385 Free article. Clinical Trial.
Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy.
Chan SK, Chan SY, Choi HC, Tong CC, Lam KO, Kwong DL, Vardhanabhuti V, Leung TW, Luk MY, Lee AW, Lee VH. Chan SK, et al. Among authors: tong cc. Front Oncol. 2020 Aug 21;10:1417. doi: 10.3389/fonc.2020.01417. eCollection 2020. Front Oncol. 2020. PMID: 32974150 Free PMC article.
Comparison of efficacy and safety of three induction chemotherapy regimens with gemcitabine plus cisplatin (GP), cisplatin plus fluorouracil (PF) and cisplatin plus capecitabine (PX) for locoregionally advanced previously untreated nasopharyngeal carcinoma: A pooled analysis of two prospective studies.
Chan SK, Chan SY, Tong CC, Lam KO, Kwong DL, Leung TW, Luk MY, Lee AW, Choi HC, Lee VH. Chan SK, et al. Among authors: tong cc. Oral Oncol. 2021 Mar;114:105158. doi: 10.1016/j.oraloncology.2020.105158. Epub 2021 Jan 25. Oral Oncol. 2021. PMID: 33508707
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
Chan SK, Lin C, Huang SH, Chau TC, Guo QJ, O'Sullivan B, Lam KO, Chau SC, Chan SY, Tong CC, Vardhanabhuti V, Kwong DLW, So TH, Ng CY, Leung TW, Luk MY, Lee AWM, Choi HCW, Pan JJ, Lee VHF. Chan SK, et al. Among authors: tong cc. Oral Oncol. 2022 Mar;126:105736. doi: 10.1016/j.oraloncology.2022.105736. Epub 2022 Feb 1. Oral Oncol. 2022. PMID: 35121396
109 results